Skip to main content

MESA LABORATORIES INC CO

For the period ended Dec 31, 2024. Filed Feb 4, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2024 · Filed Feb 4, 2025

MLAB$136.91+7.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders’ Equity

(dollars in thousands, except per share data)

Common Stock
Number of SharesAmount(Accumulated Deficit) Retained EarningsAOCI*Total
March 31, 20245,394,491$343,642$(183,494)$(14,755)$145,393
Vesting of restricted stock units and exercise of stock options20,858----
Tax withholding on vesting of restricted stock units(6,194)(571)--(571)
Dividends paid, $0.16 per share--(863)-(863)
Stock-based compensation expense-2,928--2,928
Foreign currency translation---452452
Net income--3,388-3,388
June 30, 20245,409,155$345,999$(180,969)$(14,303)$150,727
Vesting of restricted stock units and exercise of stock options13,006----
Tax withholding on vesting of restricted stock units(2,306)(307)--(307)
Dividends paid, $0.16 per share--(866)-(866)
Stock-based compensation expense-3,837--3,837
Foreign currency translation---4,6324,632
Net income--3,428-3,428
September 30, 20245,419,855$349,529$(178,407)$(9,671)$161,451
Vesting of restricted stock units and exercise of stock options13,78023--23
Tax withholding on vesting of restricted stock units(32)(3)--(3)
Dividends paid, $0.16 per share--(869)-(869)
Stock-based compensation expense-3,239--3,239
Foreign currency translation---(6,951)(6,951)
Net (loss)--(1,676)-(1,676)
December 31, 20245,433,603$352,788$(180,952)$(16,622)$155,214
Common Stock
Number of SharesAmount(Accumulated Deficit) Retained EarningsAOCI*Total
March 31, 20235,369,466$332,076$74,199$(12,795)$393,480
Vesting of restricted stock units and exercise of stock options20,07452--52
Tax withholding on vesting of restricted stock units(5,260)(712)--(712)
Dividends paid, $0.16 per share--(859)-(859)
Stock-based compensation expense-2,968--2,968
Foreign currency translation---(6,661)(6,661)
Net (loss)--(549)-(549)
June 30, 20235,384,280$334,384$72,791$(19,456)$387,719
Vesting of restricted stock units and exercise of stock options7,464304--304
Tax withholding on vesting of restricted stock units(18)(2)--(2)
Dividends paid, $0.16 per share--(862)-(862)
Stock-based compensation expense-3,183--3,183
Foreign currency translation---(1,353)(1,353)
Net (loss)--(1,230)-(1,230)
September 30, 20235,391,726$337,869$70,699$(20,809)$387,759
Vesting of restricted stock units and exercise of stock options2,4152--2
Tax withholding on vesting of restricted stock units(98)(12)--(12)
Dividends paid, $0.16 per share--(862)-(862)
Stock-based compensation expense-2,993--2,993
Foreign currency translation---10,96510,965
Net income--2,116-2,116
December 31, 20235,394,043$340,852$71,953$(9,844)$402,961

*Accumulated Other Comprehensive Income (Loss).

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.